These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1986356)

  • 1. Soluble human CD4 elicits an antibody response in rhesus monkeys that inhibits simian immunodeficiency virus replication.
    Watanabe M; Chen ZW; Tsubota H; Lord CI; Levine CG; Letvin NL
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):120-4. PubMed ID: 1986356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of simian immunodeficiency virus-infected rhesus monkeys with soluble human CD4 elicits an antiviral response.
    Watanabe M; Levine CG; Shen L; Fisher RA; Letvin NL
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4616-20. PubMed ID: 2052546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simian immunodeficiency virus inhibits bone marrow hematopoietic progenitor cell growth.
    Watanabe M; Ringler DJ; Nakamura M; DeLong PA; Letvin NL
    J Virol; 1990 Feb; 64(2):656-63. PubMed ID: 2296079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of viral RNA in CD4(-)CD8(-) and CD4(-)CD8(+) lymphocytes in vivo in rhesus monkeys infected with simian immunodeficiency virus of macaques.
    Huete JM; Chatis PA; Schmitz JE; Kuroda MJ; Letvin NL; Reimann KA
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):349-60. PubMed ID: 11242521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow monocyte/macrophages are an early cellular target of pathogenic and nonpathogenic isolates of simian immunodeficiency virus (SIVmac) in rhesus macaques.
    Mandell CP; Jain NC; Miller CJ; Dandekar S
    Lab Invest; 1995 Mar; 72(3):323-33. PubMed ID: 7898051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys.
    Watanabe N; Sypek JP; Mittler S; Reimann KA; Flores-Villanueva P; Voss G; Lord CI; Letvin NL
    AIDS Res Hum Retroviruses; 1998 Mar; 14(5):393-9. PubMed ID: 9546798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques.
    Watanabe M; Reimann KA; DeLong PA; Liu T; Fisher RA; Letvin NL
    Nature; 1989 Jan; 337(6204):267-70. PubMed ID: 2536140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A humanized, nondepleting anti-CD4 antibody that blocks virus entry inhibits virus replication in rhesus monkeys chronically infected with simian immunodeficiency virus.
    Reimann KA; Khunkhun R; Lin W; Gordon W; Fung M
    AIDS Res Hum Retroviruses; 2002 Jul; 18(11):747-55. PubMed ID: 12167266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo administration of CD4-specific monoclonal antibody: effect on provirus load in rhesus monkeys chronically infected with the simian immunodeficiency virus of macaques.
    Reimann KA; Cate RL; Wu Y; Palmer L; Olson D; Waite BC; Letvin NL; Burkly LC
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):517-25. PubMed ID: 7632466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques.
    Miller MD; Lord CI; Stallard V; Mazzara GP; Letvin NL
    J Immunol; 1990 Jan; 144(1):122-8. PubMed ID: 2153161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo administration to rhesus monkeys of a CD4-specific monoclonal antibody capable of blocking AIDS virus replication.
    Reimann KA; Burkly LC; Burrus B; Waite BC; Lord CI; Letvin NL
    AIDS Res Hum Retroviruses; 1993 Mar; 9(3):199-207. PubMed ID: 8471310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A humanized form of a CD4-specific monoclonal antibody exhibits decreased antigenicity and prolonged plasma half-life in rhesus monkeys while retaining its unique biological and antiviral properties.
    Reimann KA; Lin W; Bixler S; Browning B; Ehrenfels BN; Lucci J; Miatkowski K; Olson D; Parish TH; Rosa MD; Oleson FB; Hsu YM; Padlan EA; Letvin NL; Burkly LC
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):933-43. PubMed ID: 9223409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential significance of the cellular immune response against the macaque strain of simian immunodeficiency virus (SIVMAC) in immunized and infected rhesus macaques.
    Voss G; Nick S; Stahl-Hennig C; Coulibaly C; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2273-81. PubMed ID: 1357081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of anti-CD4 MAb hu5A8 for treatment of HIV-1 infection: preclinical assessment in non-human primates.
    Boon L; Holland B; Gordon W; Liu P; Shiau F; Shanahan W; Reimann KA; Fung M
    Toxicology; 2002 Apr; 172(3):191-203. PubMed ID: 11893418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus.
    Chen ZW; Shen Y; Zhou D; Simon M; Kou Z; Lee-Parritz D; Shen L; Sehgal P; Letvin NL
    J Virol; 2001 May; 75(10):4713-20. PubMed ID: 11312343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmas from lymphocyte- and macrophage-tropic SIVmac-infected macaques have antibodies with a broader spectrum of virus neutralization activity in macrophage versus lymphocyte cultures.
    Zhuge W; Jia F; Adany I; Narayan O; Stephens EB
    Virology; 1997 Jan; 227(1):24-33. PubMed ID: 9007055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of complement consumption by cobra venom factor on the course of primary infection with simian immunodeficiency virus in rhesus monkeys.
    Schmitz JE; Lifton MA; Reimann KA; Montefiori DC; Shen L; Racz P; Tenner-Racz K; Ollert MW; Forman MA; Gelman RS; Vogel CW; Letvin NL
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):195-202. PubMed ID: 10029251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A replication-competent adenovirus-human immunodeficiency virus (Ad-HIV) tat and Ad-HIV env priming/Tat and envelope protein boosting regimen elicits enhanced protective efficacy against simian/human immunodeficiency virus SHIV89.6P challenge in rhesus macaques.
    Demberg T; Florese RH; Heath MJ; Larsen K; Kalisz I; Kalyanaraman VS; Lee EM; Pal R; Venzon D; Grant R; Patterson LJ; Korioth-Schmitz B; Buzby A; Dombagoda D; Montefiori DC; Letvin NL; Cafaro A; Ensoli B; Robert-Guroff M
    J Virol; 2007 Apr; 81(7):3414-27. PubMed ID: 17229693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages.
    Mori K; Rosenzweig M; Desrosiers RC
    J Virol; 2000 Nov; 74(22):10852-9. PubMed ID: 11044136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.